207 related articles for article (PubMed ID: 12835228)
21. Expression of tissue factor pathway inhibitor by endothelial cells and platelets.
Maroney SA; Mast AE
Transfus Apher Sci; 2008 Feb; 38(1):9-14. PubMed ID: 18261960
[TBL] [Abstract][Full Text] [Related]
22. Release of glycosylphosphatidylinositol-anchored carboxypeptidase M by phosphatidylinositol-specific phospholipase C upregulates enzyme synthesis.
Li XY; Skidgel RA
Biochem Biophys Res Commun; 1999 Apr; 258(1):204-10. PubMed ID: 10222261
[TBL] [Abstract][Full Text] [Related]
23. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression.
Maroney SA; Cunningham AC; Ferrel J; Hu R; Haberichter S; Mansbach CM; Brodsky RA; Dietzen DJ; Mast AE
J Thromb Haemost; 2006 May; 4(5):1114-24. PubMed ID: 16689766
[TBL] [Abstract][Full Text] [Related]
24. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
25. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor.
Ott I; Miyagi Y; Miyazaki K; Heeb MJ; Mueller BM; Rao LV; Ruf W
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):874-82. PubMed ID: 10712416
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium.
Lupu C; Goodwin CA; Westmuckett AD; Emeis JJ; Scully MF; Kakkar VV; Lupu F
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2964-74. PubMed ID: 9409283
[TBL] [Abstract][Full Text] [Related]
27. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues.
Bajaj MS; Kuppuswamy MN; Manepalli AN; Bajaj SP
Thromb Haemost; 1999 Sep; 82(3):1047-52. PubMed ID: 10494762
[TBL] [Abstract][Full Text] [Related]
29. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
30. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
[TBL] [Abstract][Full Text] [Related]
31. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
Hansen JB; Svensson B; Olsen R; Ezban M; Osterud B; Paulssen RH
Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cell-surface TFPIalpha and beta.
Piro O; Broze GJ
J Thromb Haemost; 2005 Dec; 3(12):2677-83. PubMed ID: 16246254
[TBL] [Abstract][Full Text] [Related]
33. Cleavage with phospholipase of the lipid anchor in the cell adhesion molecule, csA, from Dictyostelium discoideum.
Yoshida M; Sakuragi N; Kondo K; Tanesaka E
Comp Biochem Physiol B Biochem Mol Biol; 2006 Feb; 143(2):138-44. PubMed ID: 16388974
[TBL] [Abstract][Full Text] [Related]
34. Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.
Maroney SA; Ferrel JP; Collins ML; Mast AE
J Thromb Haemost; 2008 Aug; 6(8):1344-51. PubMed ID: 18503630
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
Xu Z; Maiti D; Kisiel W; Duh EJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
[TBL] [Abstract][Full Text] [Related]
36. The presence of a glycosyl phosphatidylinositol-anchored alpha-mannosidase in boar sperm.
Kuno M; Yonezawa N; Amari S; Hayashi M; Ono Y; Kiss L; Sonohara K; Nakano M
IUBMB Life; 2000 Jun; 49(6):485-9. PubMed ID: 11032241
[TBL] [Abstract][Full Text] [Related]
37. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.
Dietzen DJ; Jack GG; Page KL; Tetzloff TA; Hall CL; Mast AE
Thromb Haemost; 2003 Jan; 89(1):65-73. PubMed ID: 12540955
[TBL] [Abstract][Full Text] [Related]
38. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
Westmuckett AD; Kakkar VV; Hamuro T; Lupu F; Lupu C
Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
[TBL] [Abstract][Full Text] [Related]
39. Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors.
Narwa R; Harris DA
Biochemistry; 1999 Jul; 38(27):8770-7. PubMed ID: 10393552
[TBL] [Abstract][Full Text] [Related]
40. Activation of the glycosylphosphatidylinositol-anchored membrane proteinase upon release from Herpetomonas samuelpessoai by phospholipase C.
dos Santos AL; Abreu CM; Alviano CS; de Araújo Soares RM
Curr Microbiol; 2002 Oct; 45(4):293-8. PubMed ID: 12192529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
